We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+0.94%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$10.4M
Cap. Flow
+$9.55M
Cap. Flow %
4.27%
Top 10 Hldgs %
54.64%
Holding
29
New
1
Increased
22
Reduced
1
Closed
2

Top Sells

Rank Stock Value
1
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
+$1.45M
2
PFE icon
Pfizer
PFE
+$1.27M
3
MS icon
Morgan Stanley
MS
+$822K

Sector Composition

Rank Sector Weight
1 Energy 21.74%
2 Healthcare 20.15%
3 Technology 12.91%
4 Industrials 10.12%
5 Consumer Discretionary 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
26
Enterprise Products Partners
EPD
$82.6B
$591K 0.26%
24,855
RUSHB icon
27
Rush Enterprises Class B
RUSHB
$5.89B
$312K 0.14%
9,761
MS icon
28
Morgan Stanley
MS
$339B
-10,805
Closed -$822K
PFE icon
29
Pfizer
PFE
$143B
-24,164
Closed -$1.27M

Similar funds

Muhlenkamp & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Muhlenkamp & Co held 29 positions worth $224M, up 4.9% from $214M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Muhlenkamp & Co deployed $9.55M of net new capital in Q3 2022, opening 1 new position and adding to 22 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 652,921 shares worth $11.7M.

By sector, the portfolio is most concentrated in Energy at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Tenneco Inc. Class A Voting Common Stock, an estimated $1.45M trimmed.

  • Muhlenkamp & Co's largest Q3 2022 buy was Direxion Daily S&P 500 Bear 1X ETF: 652,921 shares worth $11.7M.
  • Muhlenkamp & Co added most to SPDR Gold Trust in Q3 2022, an estimated $617K increase.
  • Muhlenkamp & Co's biggest Q3 2022 reduction was Tenneco Inc. Class A Voting Common Stock, cutting an estimated $1.45M.
  • Muhlenkamp & Co fully exited Pfizer in Q3 2022, selling an estimated $1.27M.
  • Muhlenkamp & Co's ten largest holdings make up 55% of its $224M portfolio in Q3 2022.
  • Muhlenkamp & Co opened 1 new position and closed 2 in Q3 2022.
  • Muhlenkamp & Co's portfolio value rose 4.9% quarter-over-quarter to $224M.

Based on Muhlenkamp & Co's 13F filing for Q3 2022, filed 1 Nov 2022.